Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2005
12/08/2005CA2586222A1 Enzymes for pharmaceutical use
12/08/2005CA2568742A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005CA2565886A1 Treatment of inflammatory airway disease
12/08/2005CA2564868A1 Methods for treating or preventing restenosis and other vascular proliferative disorders
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1439840B1 Monobactam antibacterial compounds and methods of use thereof
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1221852B1 Therapeutic use of antimicrobial compositions comprising a benzoic acid analog and a metal salt
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1155019B1 Substituted porphyrins and their therapeutic use
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005CN1705678A Therapeutic peptides
12/07/2005CN1705670A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704121A Anti-angiogenic compositions and methods of use
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230199C Use of nitric oxide for treatment of airway constriction
12/07/2005CN1230197C Y-IFN liquid-droplet aerosol and method
12/07/2005CN1230170C Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230165C Azolylcarbynol derivatives of aryl (or heteroaryl) for treatment of respiratory diseases
12/07/2005CN1230156C Fibrauretine dispersant tablet and its preparing method
12/06/2005USRE38912 for treating a number of complaints, particularly respiratory diseases
12/06/2005US6972298 Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2284774C Theobromine antitussive compositions
12/06/2005CA2268866C Substituted arylalkylamines as neurokinin antagonists
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/01/2005WO2005113483A2 Levalbuterol hydrochloride polymorph a
12/01/2005WO2005113482A1 Levalbuterol hydrochloride polymorph b
12/01/2005WO2005113481A1 Preparation of levalbuterol hydrochloride
12/01/2005WO2005065015A3 Neutralizing antibodies and methods of use thereof
12/01/2005WO2004108713A8 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
12/01/2005WO2004080964A8 Indole derivatives useful for the treatment of diseases
12/01/2005WO2004071384A3 New pharmaceutical compositions based on anticholinergics and tace-inhibitors
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267216 suspending or forming a slurry of the R enantiomer of albuterol dibenzoyl tartrate complex in at least one solvent;adding hydrogen chloride in a C1-C4 alcohol to the suspension or slurry until levalbuterol hydrochloride Polymorph B is obtained
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267155 Constrained himbacine analogs as thrombin receptor antagonists
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266084 Modified release dosage forms
12/01/2005US20050266079 Process for making aqueous coated beadlets
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005CA2556921A1 Levalbuterol hydrochloride polymorph b
12/01/2005CA2556920A1 Levalbuterol hydrochloride polymorph a
12/01/2005CA2556904A1 Preparation of levalbuterol hydrochloride
11/2005
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600170A1 Sustained-release pharmaceutical composition for lung administration
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1599475A2 Jnk inhibitors
11/30/2005EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
11/30/2005EP1599227A2 Methods of immunomodulation in animals
11/30/2005EP1599221A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
11/30/2005EP1599096A2 Hetero substitued sodium channel blockers
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP1089715B1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005EP0797666B1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
11/30/2005CN1703234A The use of low-molecular-weight thrombin inhibitor
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 878